Alpha Teknova Stock Quote TKNO - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

4.90

Bid

4.65

Ask

4.90

Volume

0.00 Day's Range 0.00

1.155 52 Week Range 5.455

Market Cap

261.185M

Previous Close

4.90

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

669,055

Shares Outstanding

53,302,993

Dividend Yield

PE Ratio

-7.10

Earnings Per Share (EPS)

-0.69

Revenue

36.68M

Net Profit

-36.78M

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture ... Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.teknova.com

Headquarters

Wilmington, Delaware, USA

Founded

Alpha Teknova Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker TKNO. The last closing price for Alpha Teknova was $4.90. Over the last year, Alpha Teknova shares have traded in a share price range of $ 1.155 to $ 5.455.

Alpha Teknova currently has 53,302,993 shares outstanding. The market capitalization of Alpha Teknova is $261.18 million. Alpha Teknova has a price to earnings ratio (PE ratio) of -7.10.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Teknova Reports Second Quarter 2024 Financial Results

Second quarter 2024 total revenue was $9.6 million, up 3% sequentiallyRaised $15.4 million of equity capital in July 2024Launched two new offerings: Express-TekSM Production and RUO+ manufacturing...

Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development

Express-TekSM Production enables customers to have their products enter production in days instead of weeks, significantly shortening turnaround time New manufacturing grade, RUO+, provides a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.47	10.6094808126	4.43	5.3899	4.25	207660	5.01201393	CS
4	-0.15	-2.9702970297	5.05	5.455	4	175855	4.72367057	CS
12	3.67	298.37398374	1.23	5.455	1.155	669055	2.91397362	CS
26	2.46	100.819672131	2.44	5.455	1.155	320948	2.86482476	CS
52	2.78	131.132075472	2.12	5.455	1.155	189947	2.87369693	CS
156	-18.01	-78.6119598429	22.91	28	1.155	102296	5.14764216	CS
260	-15.82	-76.3513513514	20.72	30.89	1.155	109364	7.58215014	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAGRAfrican Agriculture Holdings Inc	$ 0.1495 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.91 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.632415 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1495 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.91 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.632415 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	$ 0.1495 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.00 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.91 (0.00%)	0
AACIArmada Acquisition Corporation I	$ 9.75 (0.00%)	0
AACGATA Creativity Global	$ 0.632415 (0.00%)	0